| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Evgen Pharma appoints Helen Kuhlman as chief business officer
StockMarketWire.com
|
Drug development company Evgen appointed Helen Kuhlman as chief business officer starting from 1 April 2021.
Kuhlman joined Evgen from the Development Bank of Wales where she was responsible for equity investment in technology companies and for managing investments in the bank's portfolio companies.
At 9:52am: (LON:EVG) Evgen Pharma Plc share price was 0p at 8.3p
Story provided by StockMarketWire.com
|
|
|
|
|
|
